Omnitrope: Enhancing Geriatric Health by Treating Growth Hormone Deficiency
Reading Time: 2 minutesIntroduction to Omnitrope Omnitrope is a biosimilar recombinant human growth hormone (somatropin) that has been approved for the treatment of growth hormone deficiency (GHD) in both children and adults. As the population ages, the prevalence of GHD among geriatric patients has become a significant concern, prompting increased interest in the therapeutic potential of Omnitrope in this demographic. Understanding Growth Hormone... Read more »
